We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
26 hedge funds and large institutions have $58.1M invested in Enzymotec Ltd in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more capital invested
Capital invested by funds: $45.8M → $58.1M (+$12.3M)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
19% less funds holding
Funds holding: 32 → 26 (-6)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
26
Holders Change
-6
Holders Change %
-18.75%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$1.04M |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$331K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$289K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$213K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$212K |
